TrialEuropean heart journal2021

The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial.

John G F Cleland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.